Trial record 1 of 1 for:
NCT04608838
A Randomized Placebo-controlled Multicenter Trial to Evaluate the Efficacy and Safety of JTR-161, Allogeneic Human Dental Pulp Stem Cell, in Patients With Acute Ischemic stRoke (J-REPAIR) (J-REPAIR)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04608838 |
Recruitment Status :
Completed
First Posted : October 29, 2020
Last Update Posted : June 30, 2022
|
Sponsor:
Teijin Pharma Limited
Information provided by (Responsible Party):
Teijin Pharma Limited
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | February 15, 2021 |
Actual Study Completion Date : | November 24, 2021 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):